Fabrication of a new photoluminescent and pH-responsive nanocomposite based on a hyperbranched polymer prepared from amino acid for targeted drug delivery applications

Int J Pharm. 2023 Apr 5:636:122804. doi: 10.1016/j.ijpharm.2023.122804. Epub 2023 Mar 6.

Abstract

In this study, the Fe3O4 nanoparticles were encapsulated in the hyperbranched poly L-lysine citramid (HBPLC). The Fe3O4-HBPLC nanocomposite modified with L-arginine and quantum dots (QDs) to obtain Fe3O4-HBPLC-Arg/QDs as a new photoluminescent and magnetic nanocarrier for the pH-responsive release and targeted delivery of Doxorubicin (DOX). The prepared magnetic nanocarrier was fully characterized using different techniques. Its various potential as a magnetic nanocarrier was evaluated. The in-vitro drug release studies exhibited that the prepared nanocomposite has pH-responsive behavior. The antioxidant study revealed good antioxidant properties of the nanocarrier. Also, the nanocomposite revealed excellent photoluminescence with a quantum yield of 48.5 %. Cellular uptake studies showed that Fe3O4-HBPLC-Arg/QD has high cell uptake in MCF-7 cells and can be used for bioimaging applications. In-vitro cytotoxicity, colloidal stability, and enzymatic degradability studies revealed that the prepared nanocarrier is non-toxic (with cell viability of 94%), stabile and biodegradable (about 37%). The nanocarrier was hemocompatible with 8% hemolysis. Also, according to the apoptosis and MTT assays, the Fe3O4-HBPLC-Arg/QD-DOX induced greater toxicity and cellular apoptosis against breast cancer cells about 47.0 %.

Keywords: Antioxidant; Drug delivery; Hyperbranched polymer; Photoluminescent; pH-responsive.

MeSH terms

  • Amino Acids
  • Antioxidants
  • Doxorubicin / chemistry
  • Drug Carriers* / chemistry
  • Drug Delivery Systems / methods
  • Drug Liberation
  • Humans
  • Hydrogen-Ion Concentration
  • MCF-7 Cells
  • Nanocomposites*
  • Polymers

Substances

  • Drug Carriers
  • Polymers
  • Amino Acids
  • Antioxidants
  • Doxorubicin